Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension

Ann Intern Med. 2006 Jul 18;145(2):152-3. doi: 10.7326/0003-4819-145-2-200607180-00020.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antihypertensive Agents / therapeutic use*
  • Benzamides
  • Heart Failure / etiology
  • Humans
  • Hypertension, Pulmonary / complications
  • Hypertension, Pulmonary / drug therapy*
  • Imatinib Mesylate
  • Male
  • Middle Aged
  • Piperazines / therapeutic use*
  • Platelet-Derived Growth Factor / antagonists & inhibitors*
  • Pyrimidines / therapeutic use*

Substances

  • Antihypertensive Agents
  • Benzamides
  • Piperazines
  • Platelet-Derived Growth Factor
  • Pyrimidines
  • Imatinib Mesylate